Hence, Zatorski et al. studied the role of a different class of GLP medications on IBDs and concluded that GLP-2 (teduglutide) might be much more promising than GLP-1, and also suggested use of both GLPs in simultaneously can have a synergistic effect in IBD treatment through stricter attenuation of gut immune and inflammatory response [48]. Here, GCG is linked to inflammatory bowel disease.